Back to resultsIn Vitro Maturation of Immature Oocytes
Primary Purpose
Polycystic Ovary Syndrome, Ovarian Hyperstimulation Syndrome
Status
Completed
Phase
Not Applicable
Locations
Israel
Study Type
Interventional
Intervention
In Vitro Maturation of immature oocytes
Sponsored by
About this trial
This is an interventional treatment trial for Polycystic Ovary Syndrome focused on measuring PCOS, Fertility Preservation, Repeated IVF Failure, S/P Hyperstimulation
Eligibility Criteria
Inclusion Criteria:
- Women with PCOS
- Women with previous Hyperstimulation or with risk of developing hyperstimulation during IVF Treatment
- Women diagnosed with cancer who are interested in fertility preservation
- Women with repeated IVF failure
Exclusion Criteria:
- Severe cases of endometriosis
- Large myomas
- Hydrosalpinxs Technical problem with previous oocytes pick-up
Sites / Locations
- IVF Unit, Shea Medical Center, Tel-Hashomer
Outcomes
Primary Outcome Measures
Secondary Outcome Measures
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT00480337
Brief Title
In Vitro Maturation of Immature Oocytes
Study Type
Interventional
2. Study Status
Record Verification Date
December 2008
Overall Recruitment Status
Completed
Study Start Date
undefined (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
undefined (undefined)
3. Sponsor/Collaborators
Name of the Sponsor
Sheba Medical Center
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The aim of this study is to aspirate immature oocytes from antral follicles and mature the oocytes in vitro. These mature oocytes will serve for fertilization and the creation of embryos which will be replace in the uterus as performed during normal IVF.We will record the efficacy and safety of this procedure.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Polycystic Ovary Syndrome, Ovarian Hyperstimulation Syndrome
Keywords
PCOS, Fertility Preservation, Repeated IVF Failure, S/P Hyperstimulation
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
8. Arms, Groups, and Interventions
Intervention Type
Procedure
Intervention Name(s)
In Vitro Maturation of immature oocytes
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
45 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Women with PCOS
Women with previous Hyperstimulation or with risk of developing hyperstimulation during IVF Treatment
Women diagnosed with cancer who are interested in fertility preservation
Women with repeated IVF failure
Exclusion Criteria:
Severe cases of endometriosis
Large myomas
Hydrosalpinxs Technical problem with previous oocytes pick-up
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ariel Hourvitz
Organizational Affiliation
IVF Unit, Sheba Medical Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
IVF Unit, Shea Medical Center, Tel-Hashomer
City
Ramat-Gan
ZIP/Postal Code
52621
Country
Israel
12. IPD Sharing Statement
Learn more about this trial
In Vitro Maturation of Immature Oocytes
We'll reach out to this number within 24 hrs